These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
397 related articles for article (PubMed ID: 10415044)
21. Prolonged MHC class II expression and CIITA transcription in human keratinocytes. Takagi A; Nishiyama C; Kanada S; Niwa Y; Fukuyama K; Ikeda S; Okumura K; Ogawa H Biochem Biophys Res Commun; 2006 Aug; 347(2):388-93. PubMed ID: 16836979 [TBL] [Abstract][Full Text] [Related]
22. Cooperative effect of interferon-gamma and tumor necrosis factor-alpha on the induction of the class II antigen-associated invariant chain expression. Pessara U; Momburg F; Koch N Eur J Immunol; 1988 Nov; 18(11):1719-26. PubMed ID: 3144453 [TBL] [Abstract][Full Text] [Related]
23. Attenuation of MHC class II expression in macrophages infected with Mycobacterium bovis bacillus Calmette-Guérin involves class II transactivator and depends on the Nramp1 gene. Wojciechowski W; DeSanctis J; Skamene E; Radzioch D J Immunol; 1999 Sep; 163(5):2688-96. PubMed ID: 10453010 [TBL] [Abstract][Full Text] [Related]
24. Impaired class II transactivator expression in mice lacking interferon regulatory factor-2. Xi H; Goodwin B; Shepherd AT; Blanck G Oncogene; 2001 Jul; 20(31):4219-27. PubMed ID: 11464288 [TBL] [Abstract][Full Text] [Related]
25. MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance? Walter W; Lingnau K; Schmitt E; Loos M; Maeurer MJ Br J Cancer; 2000 Nov; 83(9):1192-201. PubMed ID: 11027433 [TBL] [Abstract][Full Text] [Related]
26. Toxoplasma gondii down-regulates MHC class II gene expression and antigen presentation by murine macrophages via interference with nuclear translocation of STAT1alpha. Lüder CG; Walter W; Beuerle B; Maeurer MJ; Gross U Eur J Immunol; 2001 May; 31(5):1475-84. PubMed ID: 11465104 [TBL] [Abstract][Full Text] [Related]
27. The MHC class II transactivator (CIITA) mRNA stability is critical for the HLA class II gene expression in myelomonocytic cells. De Lerma Barbaro A; Procopio FA; Mortara L; Tosi G; Accolla RS Eur J Immunol; 2005 Feb; 35(2):603-11. PubMed ID: 15627980 [TBL] [Abstract][Full Text] [Related]
28. Effects of tumor necrosis factor on the interferon-gamma-induced major histocompatibility complex class II antigen expression by human endothelial cells. Leeuwenberg JF; Van Damme J; Meager T; Jeunhomme TM; Buurman WA Eur J Immunol; 1988 Sep; 18(9):1469-72. PubMed ID: 3139431 [TBL] [Abstract][Full Text] [Related]
29. IFN-gamma-induced MHC class II gene expression is suppressed in endothelial cells by dextran sulfate. Lian RH; Kotwal GJ; Wellhausen SR; Hunt LA; Justus DE J Immunol; 1996 Jul; 157(2):864-73. PubMed ID: 8752940 [TBL] [Abstract][Full Text] [Related]
30. Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma. Lu HT; Riley JL; Babcock GT; Huston M; Stark GR; Boss JM; Ransohoff RM J Exp Med; 1995 Nov; 182(5):1517-25. PubMed ID: 7595221 [TBL] [Abstract][Full Text] [Related]
31. Ethanol inhibits prolactin- and tumor necrosis factor-alpha-, but not gamma interferon-induced expression of intercellular adhesion molecule-1 in human astrocytoma cells. DeVito WJ; Stone S; Mori K; Shamgochian M J Cell Biochem; 2000 Apr; 77(3):455-64. PubMed ID: 10760953 [TBL] [Abstract][Full Text] [Related]
32. IFN regulatory factor-1 plays a central role in the regulation of the expression of class I and II MHC genes in vivo. Hobart M; Ramassar V; Goes N; Urmson J; Halloran PF J Immunol; 1997 May; 158(9):4260-9. PubMed ID: 9126988 [TBL] [Abstract][Full Text] [Related]
33. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation. Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388 [TBL] [Abstract][Full Text] [Related]
34. Regulation of MHC class II expression in glioma cells by class II transactivator (CIITA). Takamura Y; Ikeda H; Kanaseki T; Toyota M; Tokino T; Imai K; Houkin K; Sato N Glia; 2004 Mar; 45(4):392-405. PubMed ID: 14966870 [TBL] [Abstract][Full Text] [Related]
35. Augmentation or inhibition of IFN-gamma-induced MHC class II expression by lipopolysaccharides. The roles of TNF-alpha and nitric oxide, and the importance of the sequence of signaling. Sicher SC; Chung GW; Vazquez MA; Lu CY J Immunol; 1995 Dec; 155(12):5826-34. PubMed ID: 7499872 [TBL] [Abstract][Full Text] [Related]
36. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation. Li D; Qian L; Chen C; Shi M; Yu M; Hu M; Song L; Shen B; Guo N J Immunol; 2009 Feb; 182(4):1799-809. PubMed ID: 19201831 [TBL] [Abstract][Full Text] [Related]
37. Induction of CIITA and modification of in vivo HLA-DR promoter occupancy in normal thymic epithelial cells treated with IFN-gamma: similarities and distinctions with respect to HLA-DR-constitutive B cells. Rigaud G; De Lerma Barbaro A; Nicolis M; Cestari T; Ramarli D; Riviera AP; Accolla RS J Immunol; 1996 Jun; 156(11):4254-8. PubMed ID: 8666795 [TBL] [Abstract][Full Text] [Related]
38. Inhibitor (IK) of IFN-gamma induced HLA class II antigens expression also inhibits HLA class II constitutive expression in the human Raji B cell line. Vedrenne J; Assier E; Pereno R; Bouzinba-Segard H; Azzarone B; Jasmin C; Charron D; Krief P Oncogene; 1997 Mar; 14(12):1453-61. PubMed ID: 9136989 [TBL] [Abstract][Full Text] [Related]
39. pRB is required for interferon-gamma-induction of the MHC class II abeta gene. Zhu X; Pattenden S; Bremner R Oncogene; 1999 Sep; 18(35):4940-7. PubMed ID: 10490828 [TBL] [Abstract][Full Text] [Related]
40. Glomerular mesangial cells in local inflammation. Induction of the expression of MHC class II antigens by IFN-gamma. Martin M; Schwinzer R; Schellekens H; Resch K J Immunol; 1989 Mar; 142(6):1887-94. PubMed ID: 2493501 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]